BlackRock’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02M | Sell |
|
|||||
|
2025
Q1 | $908K | Sell |
|
|||||
|
2024
Q4 | $2.55M | Buy |
|
|||||
|
2024
Q3 | $3.02M | Sell |
|
|||||
|
2024
Q2 | $3.62M | Sell |
|
|||||
|
2024
Q1 | $14.3M | Sell |
|
|||||
|
2023
Q4 | $8.71M | Sell |
|
|||||
|
2023
Q3 | $14.9M | Sell |
|
|||||
|
2023
Q2 | $20.7M | Buy |
|
|||||
|
2023
Q1 | $35.3M | Buy |
|
|||||
|
2022
Q4 | $28.9M | Buy |
|
|||||
|
2022
Q3 | $43.2M | Sell |
|
|||||
|
2022
Q2 | $36.6M | Buy |
|
|||||
|
2022
Q1 | $58.4M | Sell |
|
|||||
|
2021
Q4 | $57.3M | Buy |
|
|||||
|
2021
Q3 | $51.2M | Buy |
|
|||||
|
2021
Q2 | $90.6M | Buy |
|
|||||
|
2021
Q1 | $81.5M | Buy |
|
|||||
|
2020
Q4 | $116M | Buy |
|
|||||
|
2020
Q3 | $105M | Buy |
|
|||||
|
2020
Q2 | $121M | Buy |
|
|||||
|
2020
Q1 | $102M | Buy |
|
|||||
|
2019
Q4 | $91.4M | Buy |
|
|||||
|
2019
Q3 | $45.2M | Buy |
|
|||||
|
2019
Q2 | $27.1M | Buy |
|
|||||
|
2019
Q1 | $24.4M | Sell |
|
|||||
|
2018
Q4 | $39.9M | Sell |
|
|||||
|
2018
Q3 | $72.6M | Buy |
|
|||||
|
2018
Q2 | $68.9M | Buy |
|
|||||
|
2018
Q1 | $37M | Buy |
|
|||||
|
2017
Q4 | $25.3M | Sell |
|
|||||
|
2017
Q3 | $33.4M | Buy |
|
|||||
|
2017
Q2 | $26.8M | Buy |
|
|||||
|
2017
Q1 | $32.2M | Buy |
|
|||||
|
2016
Q4 | $39K | Sell |
|
|||||
|
2016
Q3 | $43K | Sell |
|
|||||
|
2016
Q2 | $44K | Buy |
|
|||||
|
2016
Q1 | $13K | Sell |
|
|||||
|
2015
Q4 | $34K | Buy |
|
|||||
|
2015
Q3 | $21K | Buy |
|
|||||
|
2015
Q2 | $17K | Buy |
|
|||||
|
2015
Q1 | $10K | Sell |
|
|||||
|
2014
Q4 | $3.12M | Sell |
|
|||||
|
2014
Q3 | $3.59M | Sell |
|
|||||
|
2014
Q2 | $5.04M | Buy |
|
|||||
|
2014
Q1 | $2.45M | Buy |
|
|||||
|
2013
Q4 | $60K | Buy |
|